Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (6): 5-9.doi: 10.6040/j.issn.1671-7554.0.2021.0467

Previous Articles     Next Articles

Osteoporosis in men: a chronically overlooked problem

CHENG Xiaoguang1, LU Yanhui2   

  1. 1.Department of Radiology, Beijing Jishuitan Hospital, Beijing 100035, China;
    2. Department of Endocrinology, Second Medical Center of PLA General Hospital, Beijing 100853, China
  • Published:2021-06-10

RichHTML

86

PDF (PC)

150

Abstract: Osteoporosis is a systemic bone disease. The loss of bone mass and the destruction of bone microstructure increase bone fragility and ultimately lead to an increased risk of fracture. According to etiology, primary osteoporosis can be divided into postmenopausal osteoporosis(PMO)and senile osteoporosis(SO). Osteoporosis in men is mainly SO, so the onset of osteoporosis in men is later than that in women. Due to the current dependence on dual X-ray absorptiometry(DXA)in the diagnosis of osteoporosis and the survey results of DXA, the prevalence of osteoporosis in men is considered low. In addition, there are few indications of drugs for the treatment of osteoporosis in men, resulting in the overlook of the prevention and treatment of osteoporosis in men. Therefore, it is necessary to increase the application of various testing methods, including radiology, DXA and QCT in the diagnosis of osteoporosis, as well as strengthen the awareness of osteoporosis in men and its intervention.

Key words: Osteoporosis, Male, Dual X-ray absorptiometry, Quantitative computed tomography, Anti-osteoporosis therapy

CLC Number: 

  • R574
[1] Kanis JA, Melton LJ 3rd, Christiansen C, et al. The diagnosis of osteoporosis[J]. J Bone Miner Res, 1994, 9(8): 1137-1141.
[2] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 413-414.
[3] Zeng Q, Li N, Wang Q, et al. The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey[J]. J Bone Miner Res, 2019, 34(10): 1789-1797.
[4] 程晓光,董剩勇,王亮,等.应用双能X线骨密度仪调查中国人群骨密度水平和骨质疏松症患病率[J].中华健康管理学杂志, 2019, 13(1): 51-58.
[5] 中华医学会骨质疏松和骨矿盐疾病分会.男性骨质疏松症诊疗指南[J].中华骨质疏松和骨矿盐疾病杂志, 2020, 13(5): 381-395.
[6] Berger C, Goltzman D, Langsetmo L, et al. Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis [J]. J Bone Miner Res, 2010, 25(9): 1948-1957.
[7] Si L, Winzenberg TM, Jiang Q, et al. Projection of osteoporosis-related fractures and costs in China: 2010-2050[J]. Osteoporos Int, 2015, 26(7): 1929-1937.
[8] Keene GS, Parker MJ, Pryor GA. Mortality and morbidity after hip fractures[J]. BMJ, 1993, 307(6914): 1248-1250.
[9] 中华医学会放射学分会骨关节学组,中国医师协会放射医师分会肌骨学组,中华医学会骨科学分会骨质疏松学组,等.骨质疏松的影像学与骨密度诊断专家共识[J].中华放射学杂志, 2020, 54(8): 745-752.
[10] Gao C, Xu Y, Li L, et al. Prevalence of osteoporotic vertebral fracture among community-dwelling elderly in Shanghai[J]. Chin Med J(Engl), 2019, 132(14): 1749-1751.
[11] Wáng YXJ, Che-Nordin N, Deng M, et al. Osteoporotic vertebral deformity with endplate/cortex fracture is associated with higher further vertebral fracture risk: the Ms. OS(Hong Kong)study results[J]. Osteoporos Int, 2019, 30(4): 897-905.
[12] Wang L, Ran L, Zha X, et al. Adjustment of DXA BMD measurements for anthropometric factors and its impact on the diagnosis of osteoporosis[J]. Arch Osteoporos, 2020,15(1): 155. doi: 10.1007/s11657-020-00833-1.
[13] Xu XM, Li N, Li K, et al. Discordance in diagnosis of osteoporosis by quantitative computed tomography and dual-energy X-ray absorptiometry in Chinese elderly men[J]. J Orthop Translat, 2018, 18: 59-64. doi: 10.1016/j.jot.2018.11.003.
[14] Cheng X, Zhao K, Zha X, et al. Opportunistic screening using low-dose CT and the prevalence of osteoporosis in China: a nationwide, multicenter study[J]. J Bone Miner Res, 2021, 36(3): 427-435.
[15] Schousboe JT, Ensrud KE. Opportunistic osteoporosis screening using low-Dose computed tomography(LDCT): promising strategy, but challenges remain[J]. J Bone Miner Res, 2021, 36(3): 425-426.
[16] The Lancet Diabetes Endocrinology. Osteoporosis: overlooked in men for too long[J]. Lancet Diabetes Endocrinol, 2021, 9(1):1. doi:10.1016/S2213-8587(20)30408-3.
[17] Madeo B, Zirilli L, Caffagni G, et al. The osteoporotic male: overlooked and undermanaged? [J]. Clin Interv Aging, 2007, 2(3): 305-312.
[18] Porcelli T, Maffezzoni F, Pezzaioli LC, et al. Male osteoporosis: diagnosis and management-should the treatment and the target be the same as for female osteoporosis? [J]. Eur J Endocrinol, 2020, 183(3): R75-R93.
[19] Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community[J]. Cochrane Database Syst Rev, 2012, 12(9): CD007146. doi:10.1002/14651858. CD007146.pub3.
[20] Kukuljan S, Nowson CA, Sanders KM, et al. Independent and combined effects of calcium vitamin D3 and exercise on bone structure and strength in older men: an 18-month factorial design randomized controlled trial[J]. J Clin Endocrinol Metab, 2011, 96(4): 955-963.
[21] Allison SJ, Folland JP, Rennie WJ, et al. High impact exercise increased femoral neck bone mineral density in older men: a randomised unilateral intervention[J]. Bone, 2013, 53(2): 321-328.
[22] Boonen S, Reginster JY, Kaufman JM, et al. Fracture risk and zoledronic acid therapy in men with osteoporosis[J]. N Engl J Med, 2012, 367(18): 1714-1723.
[23] Orwoll E, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men[J]. N Engl J Med, 2000, 343(9): 604-610.
[24] Ringe JD, Dorst A, Faber H, et al. Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study[J]. Rheumatol Int, 2004, 24(2): 110-113.
[25] Boonen S, Orwoll ES, Wenderoth D, et al. Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study[J]. J Bone Miner Res, 2009, 24(4): 719-725.
[26] Ringe JD, Farahmand P, Faber H, et al. Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study[J]. Rheumatol Int, 2009, 29(3): 311-315.
[27] Orwoll E, Teglbjærg CS, Langdahl BL, et al. A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density[J]. J Clin Endocrinol Metab, 2012, 97(9): 3161-3169.
[28] Langdahl BL, Teglbjærg CS, Ho PR, et al. A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial[J]. J Clin Endocrinol Metab, 2015, 100(4): 1335-1342.
[29] Orwoll ES, Scheele WH, Paul S, et al. The effect of teriparatide [human parathyroid hormone(1-34)] therapy on bone density in men with osteoporosis[J]. J Bone Miner Res, 2003, 18(1): 9-17.
[30] Kaufman JM, Orwoll E, Goemaere S, et al. Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy[J]. Osteoporos Int, 2005, 16(5): 510-516.
[1] CHEN Shihong, JIANG Dongqing, ZHUANG Xianghua, LI Xiaobo, PAN Zhe, SUN Aili, LOU Nengjun, WANG Dianhui, DU Jiaojiao, SONG Yuwen. Primary biliary cholangitis with bone pain as the main manifestation: a case report [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 98-102.
[2] LYU Li, JIANG Lu, CHEN Shihong, ZHUANG Xianghua, SONG Yuwen, WANG Dianhui, AN Wenjuan, LI Qian, PAN Zhe. Related factors of osteoporosis in 210 postmenopausal women with type 2 diabetes mellitus [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 19-25.
[3] Ping LIU,Yuwen SONG,Ping WANG,Guangwei TIAN,Fengjie ZHENG,Li LYU,Jiaojiao DU,Jing ZHANG,Xianghua ZHUANG,Shihong CHEN. Correlation between vitamin D deficiency and depression in patients with type 2 diabetes mellitus [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 51-56,102.
[4] ZHU Xuli, ZHOU Liang, WANG Yue, SUN Qingyun, CAO Mingya, DU Yuanjie, CAO Jinfeng, ZHAO Zhiming, HAO Guimin. Correlation analysis of freezing methods with different sperm sources and pregnancy outcomes [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 86-93.
[5] Xianghang LUO,Ruoyu ZHOU. Advances on the etiology and pathogenesis of osteoporosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 10-15.
[6] Shihong CHEN. Progress in glucocorticoid-induced osteoporosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 33-37.
[7] XING Xiaoping. Diagnosis and management of primary osteoporosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 1-4.
[8] Jiaojiao DU,Xianghua ZHUANG,Shihong CHEN,Xuemeng WANG,Dongqing JIANG,Fei WU,Xiaolin HAN,Mengyu HUA,Yuwen SONG. Changes of serum IL-31 and IL-33 levels in postmenopausal patients with osteoporosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 45-50.
[9] Minqi LI,Juan DU,Panpan YANG,Yuying KOU,Shanshan LIU. Research progress of oxidative stress regulating osteoporosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 16-24.
[10] XU Xiaoming, ZENG Qi, CAO Jun, CHEN Xiaorong, LYU Zhen, WANG Wo, AI Ming, KONG Yiting, KUANG Li. Associations between self-harm behavior and psychosocial-polymorphism in female freshmen [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 84-92.
[11] ZHAO Lihong, ZHAO Shuping, NIE Shenggang, SUN Jing, JIANG Tongfeng. Distribution and antimicrobial resistance of multiple pathogens in 507 males with genital tract infections [J]. Journal of Shandong University (Health Sciences), 2021, 59(1): 55-58.
[12] KANG Chengwei, LIU Lei, PU Xiaobing, TAN Gang, DONG Changchao, YAN Zhaokui. Analysis of bone metabolism and bone turnover markers in 62 cases of osteoporosis with subclinical hypothyroidism [J]. Journal of Shandong University (Health Sciences), 2020, 58(5): 82-86.
[13] LI Na, ZHANG Zhimian. Correlation of vascular calcification indicators in 138 patients aged between 39 and 81 years [J]. Journal of Shandong University (Health Sciences), 2020, 58(2): 85-89.
[14] WANG Wei, YANG Yongqin, MI Guolin. Comparison of the efficacy of escitalopram alone and with Qi Yang Yu Xin Dan Fang in the treatment of female depression with sexual dysfunction [J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 97-101.
[15] HUANG Wei, LIU Dong. Fertility improvement strategies for endometriosis associated infertility [J]. Journal of Shandong University (Health Sciences), 2019, 57(6): 23-26.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] ZHANG Jie,LI Zhen-hua,SUN Jin-hao,BAO Li-hua,LIU Yue-peng. Protective effects of the invariable magnetic field on oxidative injured Schwann cells[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(3): 229 -232 .
[2] ZHENG Min,HAO Yue-wei,LIU Xue-ping,ZHAO Ting-ting. Relationship between the HPA-2 and Kozak sequence polymorphism of platelet membrane glycoprotein and cerebral infarction[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(3): 292 -295 .
[3] WANG Shu-qin,QI Feng,WU Jian-bo,SUN Bao-zhu. Effect of calcium in ropivacaine-induced smooth muscle contraction of the aorta in rats in vitro[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(8): 773 -776 .
[4] TENG Xue-ren,ZHAO Yong-sheng,HU Guang-liang,ZHOU Lun,LI Jian-min. Characteristics of microcosmic changes following tendon allograft transplantation preserved by two methods under light microscopy and transmission electron microscopy[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(10): 945 -950 .
[5] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(8): 828 -830 .
[6] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(9): 5 -6 .
[7] NIU Rui,LIU Bo,SHAO Ming-ju,WANG Wei. mRNA expression of lunx in regional lymph nodes of non-small cell lung cancer and its correlation with prognosis[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(9): 884 -885 .
[8] JIAO Fang-fang,LIU Shi-qing,LI Fei,LI Chang-sheng,WANG Qin,SUN Qing,LU Wei. Therapeutic effects of Huayulifei on expression of SMAD7 and TGF-β in rats with bleomycin-induced pulmonary fibrosis[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(10): 1054 -1058 .
[9] ZHAO Ying， YAN Lei， ZHANG Hui， YU Peng， LI Ming-jiang， ZHAO Xing-bo. Expression of SPAG9 in patients with serous epithelial ovarian tumors[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 98 .
[10] WU Min,ZHAO Zhi-lun,WANG Jie-zhen. [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(11): 1146 -1149 .
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd